MedCity News
JULY 5, 2024
In our eagerness for innovation, there’s a risk that we ignore existing effective, readily-available treatments. The post Why Wait? The Urgency of Accessible PTSD Treatments Now appeared first on MedCity News.
Pharmaceutical Technology
JULY 5, 2024
Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in China last month.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JULY 5, 2024
When someone is sick or worried about an ailing loved one, they are already under stress. A good digital wayfinding experience can reduce that strain. The post True Blue-Dot Navigation in Healthcare is Both Harder and More Important Than You Think appeared first on MedCity News.
Pharmaceutical Technology
JULY 5, 2024
Approval is based on positive data from the Phase III FLAURA2 trial where Tagrisso plus chemotherapy showed PFS of 24.4 months.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTimes
JULY 5, 2024
The neurodegenerative disease currently affects more than 200,000 people worldwide
pharmaphorum
JULY 5, 2024
Reports indicate that private equity firms Bain Capital and Cinven may be contemplating a bid for the consumer health division of Sanofi.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JULY 5, 2024
After Labour landslide in UK general election, former shadow health secretary West Streeting sets out his objectives for the NHS.
PharmaTech
JULY 5, 2024
Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization
MedTechVets
JULY 5, 2024
JUL 6TH – We were proud to interview MedTechVet Traing Program Mentor, Scott Nelson. Scott is currently the Marketing Strategist for Wound Management and Surgical Reconstruction at LifeNet Health. Veterans have so much to offer but often limit their self-promotion which makes entering an entirely new industry very difficult. Our med tech space would benefit so much from these transitioning members that have incredible skills and experience.
Pharmaceutical Technology
JULY 5, 2024
HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer).
PharmExec
JULY 5, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, offers a description of how Femaseed works to support women who struggle with infertility.
Pharmaceutical Technology
JULY 5, 2024
BioSenic and Medsenic filed patent application with the USPTO to extend the protection for the use of arsenic trioxide (ATO) for sepsis.
PharmaTech
JULY 5, 2024
Although advancements in analytical drug substance testing are being made, the increasing diversity of the therapeutic landscape is necessitating further innovation.
Pharmaceutical Technology
JULY 5, 2024
The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of Conservative rule.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
PharmExec
JULY 5, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JULY 5, 2024
Whilst Regeneron and Sanofi secured approval in Europe for COPD, the FDA has delayed Dupixent’s application review for the disease in the US.
Pharmaceutical Commerce
JULY 5, 2024
An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.
Pharmaceutical Technology
JULY 5, 2024
The EMA has validated Philogen and Sun Pharmaceutical’s marketing authorisation application (MAA) for Nidlegy, a treatment for melanoma.
Pharmaceutical Commerce
JULY 5, 2024
An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.
Pharmaceutical Technology
JULY 5, 2024
Pendopharm has signed a distribution agreement with Ascendis Pharma to bring the hypoparathyroidism treatment, TransCon PTH, to Canada.
Pharmaceutical Commerce
JULY 5, 2024
The latest news for pharma industry insiders.
Pharmaceutical Technology
JULY 5, 2024
The UK took to the polls on 4 July 2024 and voted in a new government. How will a Labour government look for the clinical trial sector?
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmacy Times
JULY 5, 2024
Pharmacists can play a crucial role in diabetes management by implementing standing order protocols for medication titration and serving as a bridge between patients and other health care providers.
Pharmaceutical Technology
JULY 5, 2024
LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Triple-Negative Breast Cancer (TNBC).
Pharmacy Times
JULY 5, 2024
Vitamin D could mitigate negative impacts on neurobehavior and weight gain caused by consumption of monosodium glutamate (MSG).
Pharmaceutical Technology
JULY 5, 2024
As the UK transitions into a Labour party government, the pharma industry urges for boosted investment and talent attraction.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmacy Times
JULY 5, 2024
Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.
Pharmaceutical Technology
JULY 5, 2024
HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Pancreatic Cancer.
Pharmacy Times
JULY 5, 2024
A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.
Pharmaceutical Technology
JULY 5, 2024
HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Cervical Cancer.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
93 
Let's personalize your content